Literature DB >> 31436859

Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions.

M Schomaker1,2, M A Luque-Fernandez3,4,5, V Leroy6, M A Davies1.   

Abstract

Longitudinal targeted maximum likelihood estimation (LTMLE) has very rarely been used to estimate dynamic treatment effects in the context of time-dependent confounding affected by prior treatment when faced with long follow-up times, multiple time-varying confounders, and complex associational relationships simultaneously. Reasons for this include the potential computational burden, technical challenges, restricted modeling options for long follow-up times, and limited practical guidance in the literature. However, LTMLE has desirable asymptotic properties, ie, it is doubly robust, and can yield valid inference when used in conjunction with machine learning. It also has the advantage of easy-to-calculate analytic standard errors in contrast to the g-formula, which requires bootstrapping. We use a topical and sophisticated question from HIV treatment research to show that LTMLE can be used successfully in complex realistic settings, and we compare results to competing estimators. Our example illustrates the following practical challenges common to many epidemiological studies: (1) long follow-up time (30 months); (2) gradually declining sample size; (3) limited support for some intervention rules of interest; (4) a high-dimensional set of potential adjustment variables, increasing both the need and the challenge of integrating appropriate machine learning methods; and (5) consideration of collider bias. Our analyses, as well as simulations, shed new light on the application of LTMLE in complex and realistic settings: We show that (1) LTMLE can yield stable and good estimates, even when confronted with small samples and limited modeling options; (2) machine learning utilized with a small set of simple learners (if more complex ones cannot be fitted) can outperform a single, complex model, which is tailored to incorporate prior clinical knowledge; and (3) performance can vary considerably depending on interventions and their support in the data, and therefore critical quality checks should accompany every LTMLE analysis. We provide guidance for the practical application of LTMLE.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HIV treatment; TMLE; causal inference; g-methods

Mesh:

Substances:

Year:  2019        PMID: 31436859      PMCID: PMC6800798          DOI: 10.1002/sim.8340

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  38 in total

1.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

2.  Targeted minimum loss based estimation of causal effects of multiple time point interventions.

Authors:  Mark J van der Laan; Susan Gruber
Journal:  Int J Biostat       Date:  2012       Impact factor: 0.968

3.  Targeted Estimation of Marginal Absolute and Relative Associations in Case-Control Data: An Application in Social Epidemiology.

Authors:  Michelle Pearl; Laura Balzer; Jennifer Ahern
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

4.  EFFECT OF BREASTFEEDING ON GASTROINTESTINAL INFECTION IN INFANTS: A TARGETED MAXIMUM LIKELIHOOD APPROACH FOR CLUSTERED LONGITUDINAL DATA.

Authors:  Mireille E Schnitzer; Mark J van der Laan; Erica E M Moodie; Robert W Platt
Journal:  Ann Appl Stat       Date:  2014-06       Impact factor: 2.083

5.  The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death.

Authors:  Daniel Westreich; Stephen R Cole; Jessica G Young; Frank Palella; Phyllis C Tien; Lawrence Kingsley; Stephen J Gange; Miguel A Hernán
Journal:  Stat Med       Date:  2012-04-11       Impact factor: 2.373

6.  Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

Authors:  Michael Schomaker; Valeriane Leroy; Tom Wolfs; Karl-Günter Technau; Lorna Renner; Ali Judd; Shobna Sawry; Madeleine Amorissani-Folquet; Antoni Noguera-Julian; Frank Tanser; François Eboua; Maria Luisa Navarro; Cleophas Chimbetete; Clarisse Amani-Bosse; Josiane Warszawski; Sam Phiri; Sylvie N'Gbeche; Vivian Cox; Fla Koueta; Janet Giddy; Haby Sygnaté-Sy; Dorthe Raben; Geneviève Chêne; Mary-Ann Davies
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

7.  Adjusting for perception and unmasking effects in longitudinal clinical trials.

Authors:  Alan Hubbard; Farid Jamshidian; Nicholas Jewell
Journal:  Int J Biostat       Date:  2012-12-31       Impact factor: 1.829

8.  Targeted maximum likelihood estimation for a binary treatment: A tutorial.

Authors:  Miguel Angel Luque-Fernandez; Michael Schomaker; Bernard Rachet; Mireille E Schnitzer
Journal:  Stat Med       Date:  2018-04-23       Impact factor: 2.373

9.  When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.

Authors:  Michael Schomaker; Matthias Egger; James Ndirangu; Sam Phiri; Harry Moultrie; Karl Technau; Vivian Cox; Janet Giddy; Cleophas Chimbetete; Robin Wood; Thomas Gsponer; Carolyn Bolton Moore; Helena Rabie; Brian Eley; Lulu Muhe; Martina Penazzato; Shaffiq Essajee; Olivia Keiser; Mary-Ann Davies
Journal:  PLoS Med       Date:  2013-11-19       Impact factor: 11.069

10.  Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation.

Authors:  M A Gianfrancesco; L Balzer; K E Taylor; L Trupin; J Nititham; M F Seldin; A W Singer; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

View more
  4 in total

1.  Targeted maximum likelihood estimation of causal effects with interference: A simulation study.

Authors:  Paul N Zivich; Michael G Hudgens; Maurice A Brookhart; James Moody; David J Weber; Allison E Aiello
Journal:  Stat Med       Date:  2022-07-18       Impact factor: 2.497

Review 2.  The role of machine learning in clinical research: transforming the future of evidence generation.

Authors:  E Hope Weissler; Tristan Naumann; Tomas Andersson; Rajesh Ranganath; Olivier Elemento; Yuan Luo; Daniel F Freitag; James Benoit; Michael C Hughes; Faisal Khan; Paul Slater; Khader Shameer; Matthew Roe; Emmette Hutchison; Scott H Kollins; Uli Broedl; Zhaoling Meng; Jennifer L Wong; Lesley Curtis; Erich Huang; Marzyeh Ghassemi
Journal:  Trials       Date:  2021-08-16       Impact factor: 2.279

3.  The Impact of Same-Day Antiretroviral Therapy Initiation Under the World Health Organization Treat-All Policy.

Authors:  Bernhard Kerschberger; Andrew Boulle; Rudo Kuwengwa; Iza Ciglenecki; Michael Schomaker
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

Review 4.  A scoping review of studies using observational data to optimise dynamic treatment regimens.

Authors:  Maarten J IJzerman; Julie A Simpson; Robert K Mahar; Myra B McGuinness; Bibhas Chakraborty; John B Carlin
Journal:  BMC Med Res Methodol       Date:  2021-02-22       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.